Extremely high mortality rates among hemodialysis patients with COVID-19 before the era of SARS-CoV-2 vaccination: results from a large database from the North of Poland
- PMID: 34105917
- DOI: 10.20452/pamw.16028
Extremely high mortality rates among hemodialysis patients with COVID-19 before the era of SARS-CoV-2 vaccination: results from a large database from the North of Poland
Abstract
Introduction: Preliminary reports suggested high incidence and mortality rates of SARS‑ CoV 2 infection in patients receiving kidney replacement therapy.
Objectives: We aimed to describe the incidence and outcomes of COVID‑ 19 in hemodialysis patients.
Patients and methods: We conducted a retrospective multicenter cohort study on the incidence and mortality of COVID‑ 19 in hemodialysis patients as compared with the general adult population in the period from the beginning of the pandemic until the commencement of the SARS‑ CoV 2 vaccination program. The study population included all patients who were receiving hemodialysis in any of the 14 dialysis units of Pomerania Province, Poland on December 31, 2019 and all individuals who were starting long‑ term hemodialysis between January 1, 2020 and January 31, 2021, amounting to a total of 1567 patients. Data on the general population were obtained from reports of the health authorities.
Results: The absolute cumulative incidence of SARS‑ CoV 2 infection in hemodialysis patients was 22.4%, and after standardization for age it was 3.98-fold higher compared with the general population (P <0.001). The epidemic trajectory of both groups ran in parallel, but the increase and decline in the number of new cases occurred earlier in hemodialysis patients. The fatality rate of COVID‑ 19 among hemodialysis patients was 30.4%. It was the highest among the oldest patients, reaching 43.81% in individuals aged 75 years or older (P = 0.003). Age‑ standardized fatality and mortality rates in hemodialysis patients were 5.5- and 10.9-fold higher than in controls, respectively (both P <0.001).
Conclusions: The results of this study show the extremely high mortality rate of COVID‑ 19 in hemodialysis patients during the first and second waves of the epidemic in Pomerania Province, before the vaccination era.
Similar articles
-
Analysis of Experiences in Preventing COVID-19 in Hemodialysis Centers of the North of Poland before the Era of Vaccination.Int J Environ Res Public Health. 2022 Jan 7;19(2):684. doi: 10.3390/ijerph19020684. Int J Environ Res Public Health. 2022. PMID: 35055503 Free PMC article.
-
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.JAMA Netw Open. 2021 Sep 1;4(9):e2123622. doi: 10.1001/jamanetworkopen.2021.23622. JAMA Netw Open. 2021. PMID: 34473256 Free PMC article.
-
[Vaccination Against COVID-19 in a Network of Hemodialysis Units in Portugal: A Promising Experience].Acta Med Port. 2022 May 2;35(5):336-342. doi: 10.20344/amp.16250. Epub 2021 Nov 5. Acta Med Port. 2022. PMID: 34742362 Portuguese.
-
Immunogenicity of SARS-CoV-2 mRNA vaccine in dialysis and kidney transplant patients: A systematic review.Tuberk Toraks. 2021 Dec;69(4):547-560. doi: 10.5578/tt.20219612. Tuberk Toraks. 2021. PMID: 34957748 English.
-
Management and outcomes of patients on maintenance dialysis during the first and second wave of the COVID-19 pandemic in Geneva, Switzerland.Swiss Med Wkly. 2021 Aug 27;151(33-34). doi: 10.4414/SMW.2021.w30006. Swiss Med Wkly. 2021. PMID: 34495598 Review.
Cited by
-
Omicron variant infection worsen the prognosis of haemodialysis (HD) patients.Ann Med. 2024 Dec;56(1):2394582. doi: 10.1080/07853890.2024.2394582. Epub 2024 Aug 25. Ann Med. 2024. PMID: 39183464 Free PMC article.
-
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients.BMC Immunol. 2021 Oct 19;22(1):70. doi: 10.1186/s12865-021-00458-0. BMC Immunol. 2021. PMID: 34666683 Free PMC article.
-
COVID-19 Infection and Response to Vaccination in Chronic Kidney Disease and Renal Transplantation: A Brief Presentation.Life (Basel). 2022 Aug 31;12(9):1358. doi: 10.3390/life12091358. Life (Basel). 2022. PMID: 36143394 Free PMC article. Review.
-
Angiotensin Converting Enzyme Inhibitors May Increase While Active Vitamin D May Decrease the Risk of Severe Pneumonia in SARS-CoV-2 Infected Patients with Chronic Kidney Disease on Maintenance Hemodialysis.Viruses. 2022 Feb 22;14(3):451. doi: 10.3390/v14030451. Viruses. 2022. PMID: 35336859 Free PMC article.
-
Infection status and clinical characteristics of COVID-19 in maintenance hemodialysis patients in Wuhan during the omicron pandemic.Medicine (Baltimore). 2023 Sep 8;102(36):e35063. doi: 10.1097/MD.0000000000035063. Medicine (Baltimore). 2023. PMID: 37682194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous